Generic Hetlioz Does Not Require Braille Labeling, FDA Tells Vanda

Braille label
The FDA says braille is not required in labeling for generic versions of the sleep disorder drug Hetlioz. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics